Norges Bank
ADMA icon

Norges Bank’s ADMA Biologics ADMA Stock Holding History

Norges Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,133
Closed -$549K – 30
2025
Q2 		$549K Hold
30,133
– – ﹤0.01% 1616
2025
Q1 		$598K Sell
30,133
-89,211
-75% -$1.54M ﹤0.01% 1677
2024
Q4 		$2.05M Buy
+119,344
New +$2.25M ﹤0.01% 1687
2023
Q1 		– Sell
-1,793,300
Closed -$6.96M – 2089
2022
Q4 		$6.96M Buy
+1,793,300
New +$5.53M ﹤0.01% 1681

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank's ADMA Position: Q3 2025 in Review

Norges Bank sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 30,133 shares — an estimated $549K sold.

Norges Bank first reported a position in ADMA in Q4 2022 and held it in 4 quarters. The position peaked at $6.96M in Q4 2022. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Norges Bank reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 30,133 ADMA Biologics shares in Q3 2025, an estimated $549K.
  • Norges Bank first reported a position in ADMA Biologics in Q4 2022 and held it in 4 quarters.
  • Norges Bank's ADMA Biologics position peaked at $6.96M in Q4 2022.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.